ARCHIVES

High Response Rate of Hairy Cell Leukemia Patients to Immunotoxin Treatment In Phase I

This article is from The Cancer Letter archive.

Vol. 24 No. 4 | April 27, 2001

Download PDF Visit The Full Archive

Related Articles

DCT To Examine Groups’ Studies, Directions, Role in 2000 A.D. Goal

June 8, 1984

Satraplatin Improved PFS In Refractory Prostate Cancer

July 25, 2003

Part One Of A Two-Part Interview With NCI Director Harold Varmus

July 22, 2011

NCI Cooperative Group, Cancer Center Trials Listed

July 27, 2007

CCOP Discussion Dominate ACCC Annual Meeting

March 12, 1982

Cancer survivors number 9.8 million in U.S., CDC says.

June 25, 2004